Fairvalue-Calculator Fairvalue-Calculator
EN DE

American Healthcare REIT, Inc (AHR) Fair Value & Analysis

Real Estate · US · Market cap $9.6B

Price$50.10
Fair Value$11.04
Upside-78.0%
Quality94/100
Evidence: High Range $5.70 – $11.04

Analysis

American Healthcare REIT, Inc (AHR) currently trades at $50.10, while our model-based Fair Value estimate is $11.04 — implying the stock looks roughly 78.0% overvalued today. We read business quality at 94/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements. American Healthcare REIT, Inc. is based in Irvine, United States.

Open the full interactive analysis →

Similar stocks

Welltower Inc (WELL) -77% Ventas, Inc (VTR) -79% Omega Healthcare Investors, Inc (OHI) -11% Healthpeak Properties, Inc (DOC) -82% CareTrust REIT, Inc (CTRE) -41% Healthcare Realty Trust Incorporated (HR) +31%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.